---
figid: PMC7400772__ol-20-03-2075-g00
figlink: pmc/articles/PMC7400772/figure/f1-ol-0-0-11774/
number: F1
caption: 'Mechanisms of immune evasion in EC. The mechanisms mainly include the inhibition
  of T-lymphocyte activity by the AKT/NF-κB/IκB/COX-2 signaling pathway, VISTA and
  TAMs; the inhibition of NK cell activity by IDO and PIBF; gene mutation (JAK1, MUC16
  and NLRC5); the promotion of EC cell sensitivity to estrogen by IL4/IL13-induced
  CD68+CD163+ macrophages; and the promotion of PD-L1 protein expression by estrogen.
  CTL, cytotoxic T lymphocyte; EC, endometrial cancer; ER-α: estrogen receptor-α;
  JAK1, Janus kinase 1; IDO, indoleamine 2,3-dioxygenase; IL, interleukin; MSI, microsatellite
  instability; MHC, major histocompatibility complex; NK, natural killer; NLRC5, NLR
  family, caspase recruitment domain-containing 5; PD-1, programmed cell death-1;
  PD-L1, PD-1 ligand 1; Treg, regulatory T cell; Th, T helper cell; IFN, interferon;
  TGF-β, transforming growth factor-β; TNF-α, tumor necrosis factor-α; NF-κB, nuclear
  factor-κB; IκB, inhibitor of κB; COX-2, cyclooxygenase-2; MUC16, mucin 16; TIL,
  tumor-infiltrating lymphocyte; OS, overall survival; PI3K, phosphoinositide 3-kinase;
  TAM, tumor-associated macrophage; VISTA, V-set immunoregulatory receptor; LMP-2,
  latent membrane protein 2; TAP-1, Transporter-1, ATP-binding cassette subfamily
  B member; PIBF, progesterone-induced blocking factor.'
pmcid: PMC7400772
papertitle: 'Immune disorder in endometrial cancer: Immunosuppressive microenvironment,
  mechanisms of immune evasion and immunotherapy.'
reftext: Lei Zhan, et al. Oncol Lett. 2020 Sep;20(3):2075-2090.
pmc_ranked_result_index: '18159'
pathway_score: 0.9695524
filename: ol-20-03-2075-g00.jpg
figtitle: Immune evasion in EC
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7400772__ol-20-03-2075-g00.html
  '@type': Dataset
  description: 'Mechanisms of immune evasion in EC. The mechanisms mainly include
    the inhibition of T-lymphocyte activity by the AKT/NF-κB/IκB/COX-2 signaling pathway,
    VISTA and TAMs; the inhibition of NK cell activity by IDO and PIBF; gene mutation
    (JAK1, MUC16 and NLRC5); the promotion of EC cell sensitivity to estrogen by IL4/IL13-induced
    CD68+CD163+ macrophages; and the promotion of PD-L1 protein expression by estrogen.
    CTL, cytotoxic T lymphocyte; EC, endometrial cancer; ER-α: estrogen receptor-α;
    JAK1, Janus kinase 1; IDO, indoleamine 2,3-dioxygenase; IL, interleukin; MSI,
    microsatellite instability; MHC, major histocompatibility complex; NK, natural
    killer; NLRC5, NLR family, caspase recruitment domain-containing 5; PD-1, programmed
    cell death-1; PD-L1, PD-1 ligand 1; Treg, regulatory T cell; Th, T helper cell;
    IFN, interferon; TGF-β, transforming growth factor-β; TNF-α, tumor necrosis factor-α;
    NF-κB, nuclear factor-κB; IκB, inhibitor of κB; COX-2, cyclooxygenase-2; MUC16,
    mucin 16; TIL, tumor-infiltrating lymphocyte; OS, overall survival; PI3K, phosphoinositide
    3-kinase; TAM, tumor-associated macrophage; VISTA, V-set immunoregulatory receptor;
    LMP-2, latent membrane protein 2; TAP-1, Transporter-1, ATP-binding cassette subfamily
    B member; PIBF, progesterone-induced blocking factor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - JAK3
  - TAP1
  - PSMB9
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - CD8A
  - CD8B
  - VSIR
  - AKT2
  - AKT3
  - AKT1
  - IL12A
  - IL12B
  - CCL22
  - IL10
  - MUC16
  - NLRC5
  - CGA
  - LHB
  - IDO1
  - IL4
  - IL13
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - IL17A
  - CD274
  - NO2
  - Estrogen
  - Estradiol
  - estrogen
  - Cytotoxic
genes:
- word: JAKI
  symbol: JAKL
  source: hgnc_alias_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: TAP1
  symbol: TAP1
  source: hgnc_symbol
  hgnc_symbol: TAP1
  entrez: '6890'
- word: LMP2,
  symbol: LMP2
  source: hgnc_prev_symbol
  hgnc_symbol: PSMB9
  entrez: '5698'
- word: JAKImutationHIFN-y,LMP2,TAP1
  symbol: LMP2
  source: hgnc_prev_symbol
  hgnc_symbol: PSMB9
  entrez: '5698'
- word: JAKImutationHIFN-y,LMP2,TAP1
  symbol: TAP1
  source: hgnc_symbol
  hgnc_symbol: TAP1
  entrez: '6890'
- word: NF-KB/IKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-KB/IKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-KB/IKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-KB/IKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-KB/IKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: CD8*
  symbol: CD8
  source: bioentities_symbol
  hgnc_symbol: CD8A
  entrez: '925'
- word: CD8*
  symbol: CD8
  source: bioentities_symbol
  hgnc_symbol: CD8B
  entrez: '926'
- word: VISTA
  symbol: VISTA
  source: hgnc_alias_symbol
  hgnc_symbol: VSIR
  entrez: '64115'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: →IL-12
  symbol: IL12
  source: bioentities_symbol
  hgnc_symbol: IL12A
  entrez: '3592'
- word: →IL-12
  symbol: IL12
  source: bioentities_symbol
  hgnc_symbol: IL12B
  entrez: '3593'
- word: CL17,CCL22
  symbol: CCL22
  source: hgnc_symbol
  hgnc_symbol: CCL22
  entrez: '6367'
- word: CCL22
  symbol: CCL22
  source: hgnc_symbol
  hgnc_symbol: CCL22
  entrez: '6367'
- word: <IL-10,
  symbol: IL10
  source: hgnc_symbol
  hgnc_symbol: IL10
  entrez: '3586'
- word: <IL-10,TGF-ß-
  symbol: IL10
  source: hgnc_symbol
  hgnc_symbol: IL10
  entrez: '3586'
- word: MUC16
  symbol: MUC16
  source: hgnc_symbol
  hgnc_symbol: MUC16
  entrez: '94025'
- word: NLRC5
  symbol: NLRC5
  source: hgnc_symbol
  hgnc_symbol: NLRC5
  entrez: '84166'
- word: IH
  symbol: LH
  source: bioentities_symbol
  hgnc_symbol: CGA
  entrez: '1081'
- word: IH
  symbol: LH
  source: bioentities_symbol
  hgnc_symbol: LHB
  entrez: '3972'
- word: IDO
  symbol: IDO
  source: hgnc_prev_symbol
  hgnc_symbol: IDO1
  entrez: '3620'
- word: IL-4/IL-13
  symbol: IL-4
  source: hgnc_alias_symbol
  hgnc_symbol: IL4
  entrez: '3565'
- word: IL-4/IL-13
  symbol: IL-13
  source: hgnc_alias_symbol
  hgnc_symbol: IL13
  entrez: '3596'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: IL-17A
  symbol: IL-17A
  source: hgnc_alias_symbol
  hgnc_symbol: IL17A
  entrez: '3605'
- word: PD-L1
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
chemicals:
- word: NO2
  source: MESH
  identifier: C021591
- word: Estrogen
  source: MESH
  identifier: D004967
- word: Estradiol
  source: MESH
  identifier: D004958
- word: estrogen
  source: MESH
  identifier: D004967
diseases:
- word: Cytotoxic
  source: MESH
  identifier: D064420
figid_alias: PMC7400772__F1
redirect_from: /figures/PMC7400772__F1
figtype: Figure
---
